BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Drug Development

  Aoxing Pharmaceutical Company Inc. Initiates Registration Clinical Trial of Buprenorphine / Naloxone Sublingual Tablets for Opioid Addiction Treatment

  December 6, 2010

   · 

  3 min read
• Business

  Asuragen, Inc. Announces Collaboration on the Development of BCR-ABL1 RNA IS Calibrators and Laboratory Software Reporting Tool at American Society of Hematology

  December 6, 2010

   · 

  1 min read
• Drug Development

  Fraunhofer USA Center for Molecular Biotechnology Initiates Phase I Clinical Trial for Avian (H5N1) Influenza Vaccine

  December 6, 2010

   · 

  1 min read
• Drug Development

  ZIOPHARM Oncology, Inc. Presents New Darinaparsin Preclinical Lymphoma Data at American Society of Hematology Annual Meeting

  December 6, 2010

   · 

  1 min read
• Policy

  Cubist Pharmaceuticals, Inc. Files Citizen Petition with FDA

  December 6, 2010

   · 

  1 min read
• Compugen Ltd. Release: New Studies Support Therapeutic Potential of Compugen Discovered Target for Multiple Myeloma Treatment

  December 6, 2010

   · 

  1 min read
• Drug Development

  Incyte Corporation Presents Positive Long-Term Results from Ongoing Phase II Trial of INCB18424 in Advanced Polycythemia Vera (PV) and Essential Thrombocythemia (ET) at the American Society of Hematology Annual Meeting

  December 6, 2010

   · 

  1 min read
• Drug Development

  Immunomedics, Inc.'s Results From Phase II Trial of Epratuzumab and Rituximab as Initial Treatment for Follicular Lymphoma Reported in an Oral Presentation at American Society of Hematology

  December 6, 2010

   · 

  1 min read
• Biotech Bay

  StemCells Inc. Expands SC Proven(R) Product Portfolio With Launch of Proprietary Human Cell Detection Antibodies

  December 6, 2010

   · 

  1 min read
• China Nuokang Bio-Pharmaceutical Inc. to Participate in 29th Annual J.P. Morgan Healthcare Conference

  December 6, 2010

   · 

  1 min read